Criticism, confusion and hope: new Alzheimer’s drug receives messy welcome
By
Alicia Lasek
Jun 15, 2021
Clinicians’ responses to the controversial approval of Aduhelm range between excitement and disapproval, with questions abounding on how to advise patients on treatment and the cost to patients and...
Exercise may keep mild cognitive impairment from advancing to dementia
By
Alicia Lasek
Nov 13, 2020
Study participants who began a weekly exercise routine after diagnosis with MCI had an 11% lower risk of progressing to Alzheimer’s when compared with people who did not exercise at all, a new study...
FDA advisers vote ‘no’ on drug that may slow Alzheimer’s progression
By
Alicia Lasek
Nov 09, 2020
If approved by the FDA, aducanumab would be the first-ever drug marketed to slow progression of the brain-wasting disease, according to its developer. But an advisory committee was unconvinced of the drug’s...
Alzheimer’s drug gets FDA support ahead of Friday vote on approval
By
Alicia Lasek
Nov 05, 2020
Documents released on Wednesday show that the agency’s staff members already are enthusiastic about the drug’s prospects. If approved, aducanumab could be the first drug on the market to slow Alzheimer’s...
Rural seniors with dementia have longer nursing home stays, study finds
By
Alicia Lasek
Oct 23, 2020
Rural Medicare recipients with Alzheimer’s and related dementias have longer nursing home stays and shorter survival time following diagnosis than their urban peers, investigators say.
Falls may be an Alzheimer’s precursor, study finds
By
Alicia Lasek
Oct 14, 2020
Early brain changes may be the culprit when an older person with no signs of cognitive decline has a fall, researchers say. Such falls tend to occur about five years before memory loss and confusion arise.
Clinical Briefs for Friday, May 22
By
Alicia Lasek
May 21, 2020
Infection control problems ‘persisted’ at nursing homes prior to pandemic: GAO … New AARP report spotlights Alzheimer’s toll on women … Emerging medical countermeasures to COVID-19 may be best...
Clinical Briefs for Monday, April 13
By
Alicia Lasek
Apr 12, 2020
More than 2,200 COVID-19 deaths in nursing homes … Lack of data, testing puts residents at risk of coronavirus: provider survey … More evidence found that ultrasound can aid in delivering future Alzheimer’s...
PPIs do not raise dementia risk, review finds
By
Alicia Lasek
Jan 06, 2020
There is no link between a common class of acid reflux medications and increased dementia risk, according to a new analysis.
Do you want to know that you’ll develop Alzheimer’s? For many, the answer is yes
By
Alicia Lasek
Jan 02, 2020
Most adults want to know that they have Alzheimer’s disease before symptoms appear, finds a UK survey. And 75% are willing to be tested.